Searched for
BIOLOGICAL E
Corbevax vaccine gets WHO Emergency Use Listing authorisationThe company supplied 100 million doses of Corbevax to the central government which were then utilized in pan-India immunization campaigns, ...- Biological E seeks nod for bivalent vax trialsBiological E has developed the protein subunit Covid vaccine Corbevax. The antigen used in the vaccine was developed by Texas Children’s Ho...
- Biological E to invest Rs 1800 crore to augment vaccine capacity, injectables, R&DAccording to a press release issued by the state government, the expansion is primarily targeted to ramp up the manufacturing of vaccines a...
- COVID-19: Government to expedite process of recognition of Biological E Corbevax by other countries"It is necessary to quickly initiate the process of recognition of the Corbevax vaccine and its certificate by other countries while Biolog...
- Biological E asked to give more info on Corbevax for 5-12 year-oldsBiological E had presented interim safety and immunogenicity data of phase 2/3 clinical trials conducted on participants aged 5 to 18 years.
- Biological E aims to produce 100 mn doses/month of Corbevax from Feb 2022Biological E. Limited plans to complete production at a rate of 75 million doses of its COVID-19 vaccine Corbevax per month, anticipating o...
- U.S., India's Biological E. finalise $50 mln financing deal for COVID-19 shotsUS & Biological E finalise financing agreement to expand the company's capacity to produce COVID-19 shots.
- Biological E seeks DCGI's nod for phase-3 trial of Corbevax as booster dose in those vaccinated with Covishield or CovaxinCurrently, phase 2/3 clinical trials of the second indigenously developed Corbevax, an RBD protein sub-unit vaccine to be administered in a...
- Biological E's Corbevax gets nod for phase 2/3 trials on those aged 5-18India's drug regulator has granted permission to Hyderabad-based Biological E Limited to conduct phase 2/3 clinical trials of its COVID-19 ...
- Mansukh Mandaviya holds meeting with Biological-E MD on progress of Covid vaccine Corbevax"Met Ms Mahima Datla, MD of @Biological_E , who briefed me on the progress of their upcoming #COVID19 vaccine, Corbevax. I assured all the ...
- Biological E signs pact to manufacture Providence vaccineUnder the agreement, Providence will provide the necessary technology transfer for Biological E to manufacture mRNA vaccines in India with ...
- Centre inks deal with Hyderabad-based Biological-E for second Made-In-India Covid shotThe vaccine, which is currently undergoing phase-3 clinical trials, is likely to be available in the next few months, the health ministry s...
- India's Biological E. to make Providence Therapeutics' mRNA COVID-19 vaccineProvidence will sell up to 30 million doses of its mRNA vaccine, PTX-COVID19-B, to Biological E., and will also provide the necessary techn...
- India's Biological E. to produce Johnson & Johnson's COVID-19 vaccineBiological E., based in the southern Indian city of Hyderabad, also plans to produce 75 million to 80 million doses of its own vaccine a mo...
- Biological E jabs may hit market by August, says Dr VK PaulAs per the ICMR , Biological E is testing a two-dose vaccine. Similar to Bharat Biotech’s Covaxin, Biological E’s vaccine under trial presc...
- Biological E may fill global supply gaps of Johnson & Johnson jabsIndia may have to wait for bridging trialJ&J’s deal with Biological E is a global supply agreement and the company will be tapped to meet c...
- CEPI to invest $5m in Biological E’s projectCEPI has also agreed to an initial contribution of up to $5 million to Hyderabad-based Biological E towards the cost of scaling up the proc...
- Biological E signs pact with J&J for Covid-19 vaccine technologyBiological E will produce J&J's vaccine at its vaccine production facilities and sell them both in India and export across various global m...
- Biological E may raise 620 crore via stake saleVaccine company Biological E plans to raise about Rs 620 crore by selling up to 25% stake to financial or strategic investors.
- Agreement with Biological E to lower cost of vaccine: GAVIGAVI Alliance was created in 2000 to accelerate the introduction of new vaccines so that all children.
Load More
